Tolerance by Engaging Antigen During Cellular Homeostasis
Clinical trial NCT03504241 · COMPLETED
Trial details
- NCT number
- NCT03504241
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-30
- Primary completion
- 2023-09-06
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.